Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer
{{output}}
Lung cancer remains the leading cause of cancer-related deaths, with a poor prognosis. Of the two types, non-small cell lung cancer (NSCLC) is the major and most prevalent type and associated with low response rates to the current treatment options. Sorafenib,... ...